Rezultati pretrage - So-Hyeon Gwon

Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung... od Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Youngjoo Lee, Dong‐Wan Kim, Sang‐We Kim, Ki Hyeong Lee, Won-Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak‐Hoon Son, Myung‐Ju Ahn